Skip to main content
. 2023 May 24;14:1163908. doi: 10.3389/fphar.2023.1163908

FIGURE 4.

FIGURE 4

Forest plots for the safety of the treatment-emergent adverse events and the risk ratio of cardiovascular events, vascular-access complications, hypertension, gastrointestinal disorder, hyperkalemia, and cancer. ESAs, erythropoiesis-stimulating agents; RR, risk ratio; and 95% CI, 95% confidence interval.